Pfizer Inc. will merge with Allergan PLC in a deal valued at $160bn, representing the largest health care merger ever, the companies announced Nov. 23. The mega-deal will yield the largest drug company in the world with pro forma 2015 sales of roughly $64bn, and importantly it will position Pfizer to lower its tax rate by redomiciling to Dublin, Ireland, the main driver of the deal.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?